Loading…

P179 Lenvatinib plus Pembrolizumab (L+P) vs. Sunitinib (S) in advanced Renal Cell Carcinoma (aRCC): Patterns of progression and subsequent therapy in the CLEAR trial

Saved in:

Bibliographic Details
Published in:	European urology open science (Online) 2024-11, Vol.69, p.228-229
Main Authors:	Grünwald, V., Motzer, R.J., Keizman, D., Bedke, J., Schmidinger, M., Staehler, M.D., Matveev, V.B., George, S., Hutson, T.E., Vaishampayan, U.N., Merchan, J.R., Eto, M., Rha, S.Y., Waddell, T., Sabbatini, R., Barthelemy, P., Burgents J., E., Ren, M., Brown, I., Choueiri T., K.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!